Updated from 7:09 a.m. EDT

Health care stocks generally have underperformed most other sectors during the last year or two. This underperformance could offer an opportunity for short-squeeze plays from heavily shorted biotechnology, health facilities, pharmaceutical and medical equipment stocks.

A short squeeze takes place when a stock's short-sellers are forced to cover their positions quickly when the stock they are betting against starts climbing on positive news. As the short-sellers are forced to cover, the price of the stock often moves even higher.

The metric for measuring short-squeeze plays is the short ratio, which represents the number of days it would take a stock's short sellers to cover their positions based on the stock's recent average daily trading volume.

Stockpickr has compiled the Top Health Care Short-Squeeze Plays, a list of heavily shorted stocks in the sector that have the potential to climb higher on any positive catalyst.

One of the most heavily shorted health care-related stocks is HealthSouth Corp. ( HLS), an inpatient rehabilitation services provider with a short ratio of 40. In 2003, a fraud scheme sent shares plummeting. The company is slated to report its most recent quarterly results on May 7. The stock has a forward price-to-earnings (P/E) ratio of 33 and a P/E-to-growth (PEG) ratio of 6.6.

HealthSouth shares are owned by Highfields Capital Management, $8.3 billion hedge fund. Highfields also holds shares of Clear Channel Communications ( CCU), which has a 3 short ratio, Qualcomm ( QCOM), which has a 1.2 short ratio, and PNC Financial Services ( PNC), with a 3 short ratio.

Another stock with a significant short interest is Sciele Pharma ( SCRX), a cardiovascular and diabetes pharmaceutical company that has a short ratio of about 18. The company just announced that the Food and Drug Administration has accepted the new-drug application submitted by Addrenex Pharmaceuticals for CloniBID to treat hypertension. Sciele licensed CloniBID from Addrenex for the treatment of hypertension in June 2007. Sciele earlier this week launched a $100 million stock-buyback plan. Sciele has a forward P/E ratio of 8 and a PEG ratio of 0.5.

Sciele appears in the portfolio of the Stratton Small-Cap Value Fund, which is rated four stars by Morningstar. Stratton also holds shares of CommScope ( CTV), which has a short ratio of 4, Anixter International ( AXE), with a short ratio of 10, and Terex ( TEX), with a 2.4 short ratio.

Prestige Brands ( PBH) is another heavily shorted stock, with a short ratio of 21. This distributor of over-the-counter health-care drugs and personal products has scheduled its earnings call for May 15. The stock has a forward P/E ratio of 12 and a PEG ratio of 1.5.

Prestige stock is owned by Millennium Partners, a $5 billion New York hedge fund. Millennium also own shares of Altria ( MO), which has a short ratio of 0.9, NRG Energy ( NRG), with a 5.4 short ratio, and McKesson ( MCK), with a 2.6 short ratio.

For more heavily shorted stocks in the sector, check out the Top Health-Care Short-Squeeze Plays at Stockpickr.com.
At the time of publication, Altucher and/or his fund had no positions in stocks mentioned, although positions may change at any time.

James Altucher is president of Stockpickr LLC, a wholly owned subsidiary of TheStreet.com and part of its network of Web properties, and a managing partner at Formula Capital, an alternative asset management firm that runs a fund of hedge funds. He is also a weekly columnist for the Financial Times and the author of Trade Like a Hedge Fund, Trade Like Warren Buffett and SuperCa$h. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. Altucher appreciates your feedback; click here to send him an email.

TheStreet.com has a revenue-sharing relationship with Trader's Library under which it receives a portion of the revenue from purchases by customers directed there from TheStreet.com.

If you liked this article you might like

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup

This Week's 'Barron's' Roundup